Agrawal L, et al. - Researchers performed an analysis of data collected during the Veterans Affairs Diabetes Trial (VADT) and the follow-up study (VADT-F) to assess whether intensive (INT) compared with standard (STD) glycaemic control during the VADT resulted in better long-term kidney outcomes. In individuals with type 2 diabetes who had received INT for a median of 5.6 years, observations revealed a 34% higher odds of maintaining an eGFR of >60 ml min^-1 1.73 m^-2 and of improving the Kidney Disease Improving Global Outcomes (KDIGO) category after just over 11 years of follow-up.